News | January 16, 2015

ImaCor Introduces All-In-One Hemodynamic Management Platform to Critical Care Community

New platform will be on display at EAST, SCCM and STS annual meetings

Ultrasound, Transesophageal, cardiovascular ultrasound, Zura EVO1

Image courtesy of ImaCor

January 16, 2015 — ImaCor Inc. will be showcasing for the first time Zura EVO1, its all-in-one platform for advanced hemodynamic management, at three annual scientific meetings: EAST (Eastern Association for the Surgery of Trauma), SCCM (Society of Critical Care Medicine) and STS (Society of Thoracic Surgeons). The new capabilities are imaging features at 7 MHz and 18 cm depth, hemodynamic trending data of cardiac filling and function and availability of a transthoracic echocardiography (TTE) probe for complementary hemodynamic management.

ImaCor’s all-in-one hemodynamic management platform offers hTEE, which is enabled by a miniaturized, disposable probe that can be left indwelling for up to 72 hours of direct continuous visualization. Most recently, a retrospective analysis at St. George’s Healthcare NHS Trust in London demonstrated that 195 hTEE evaluations resulted in the change in therapy of 41 patients, which ultimately improved hemodynamic parameters in 80.5% of patients. RV failure was diagnosed in almost 70% of patients, of which hTEE had a direct therapeutic impact in 68 percent. The study is available online at the Journal of Cardiothoracic and Vascular Anesthesia.

For more information: www.imacorinc.com

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the
EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

News | Cardiovascular Ultrasound | November 14, 2019
November 14, 2019 — Ultromics has received 510(k) clearance from the U.S.
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...
Digital Health Devices Used at Point of Care May Improve Diagnostic Certainty
News | Cardiovascular Ultrasound | August 05, 2019
A West Virginia-based rural medical outreach event showcased the use of point-of-care technology in an ambulatory...